Barclays Starts United Therapeutics Corp. (UTHR) at Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
BTIG Starts United Therapeutics Corp. (UTHR) at Neutral
January 5, 2015 5:42 PM ESTBTIG initiated coverage on United Therapeutics Corp. (NASDAQ: UTHR) with a Neutral rating. Analyst Hartaj Singh views risk/reward as balanced.
"A late-2017 patent cliff for 3 out of 4 of its top products that could reduce 2018 adjusted EPS to 2013 levels (~$6-7/share) is... More
